Not applicableLooking for participantsNCT05722392What this trial is testingSafety and Efficacy of Two-step Radical ProstatectomyWho this might be right forProstate Cancer Sun Yat-sen University 30
Not applicableNot Yet RecruitingNCT07492381What this trial is testingA Prospective, Single-Arm, Pilot Study of the ALPFA BPH PFA System in Men With Low, Intermediate and High-Risk Prostate CancerWho this might be right forProstate Cancer ALPFA Medical 50
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07152067What this trial is testingStereotactic Focal Radiotherapy as an Alternative Treatment to Active Surveillance for Low and Intermediate Risk Prostate CancerWho this might be right forMacroscopic Tumor Visualized at MRITumor Size Allowing Partial Prostate Treatment VolumeCAPRA SCORE ≤5 Centre Hospitalier Universitaire de Liege 146
Not applicableActive Not RecruitingNCT00890006What this trial is testingAdvanced Imaging for Radiotherapy Treatment Planning and Guidance for Low-Intermediate Risk Prostate Cancer (Margin)Who this might be right forLow or Intermediate Risk Prostate Cancer University Health Network, Toronto 99
Not applicableStudy completedNCT04307056What this trial is testingEvaluation of HIFU in TREATMENT OF LOCALIZED PROSTATE CANCER and OF RECURRENCE AFTER RADIOTHERAPYWho this might be right forProstate CancerUltrasound Therapy Association Francaise d'Urologie 3,862
Not applicableUnknownNCT04045756What this trial is testingFocal Laser Ablation for the Treatment of Focal Low-Intermediate Risk Prostate CancerWho this might be right forProstate Cancer University of Rome Tor Vergata 50
Large-scale testing (Phase 3)Active Not RecruitingNCT02692105What this trial is testingComparison of HDR vs. LDR Brachytherapy as Monotherapy for Intermediate Risk Prostate CancerWho this might be right forProstate Cancer British Columbia Cancer Agency 60
Not applicableEnded earlyNCT02454517What this trial is testingDiet and Exercise Program to Promote Weight Loss and Improve Health in Men With Low- or Low-Intermediate-Risk Prostate CancerWho this might be right forProstate AdenocarcinomaStage I Prostate Cancer AJCC V7Stage IIA Prostate Cancer AJCC v7 Fred Hutchinson Cancer Center 117
Not applicableStudy completedNCT02342626What this trial is testingDevel. and Eval. of an Active Surveillance Decision Aid for Men With Low or Intermediate Grade Prostate CancerWho this might be right forAdenocarcinoma of Prostate University of Rochester 140
Testing effectiveness (Phase 2)Study completedNCT02499848What this trial is testingEvaluate, Safety and Tolerability of Intraprostatic PRX302 Administration, Low to Intermediate Risk Prostate CancerWho this might be right forProstate Cancer Sophiris Bio Corp 18
Not applicableEnded earlyNCT03740191What this trial is testingSpot-Scanning Based Hypofractionated Proton Therapy for Low and Intermediate Risk Prostate CancerWho this might be right forLow Risk Prostate CancerIntermediate Risk Prostate Cancer EBG MedAustron GmbH 5
Not applicableStudy completedNCT02361515What this trial is testingHypofractionated Radiotherapy Versus Stereotactic Irradiation With Hyaluronic AcidWho this might be right forProstatic Adenocarcinoma Hospices Civils de Lyon 96
Not applicableLooking for participantsNCT06027892What this trial is testingTwo-fraction Versus Five-fraction Stereotactic Radiotherapy for Localized Prostate CancerWho this might be right forPROSTATE CANCER Rabin Medical Center 562
Not applicableLooking for participantsNCT07348367What this trial is testingA Comparison of Radical Prostatectomy and Precision Prostatectomy in Low- and Intermediate-risk Prostate Cancers.Who this might be right forProstatectomy Henry Ford Health System 160
Not applicableLooking for participantsNCT05832736What this trial is testingRobotic Hemi-Prostatectomy With Urethral Preservation in Low and Intermediate Risk Monolateral Prostate CancerWho this might be right forProstate Cancer Fondazione del Piemonte per l'Oncologia 36
Not applicableActive Not RecruitingNCT01352429What this trial is testingMild Hypofractionation With Proton Therapy or IMRT for Intermediate-Risk Prostate CancerWho this might be right forProstate Adenocarcinoma Abramson Cancer Center at Penn Medicine 303
Testing effectiveness (Phase 2)Active Not RecruitingNCT05100472What this trial is testingShorter Course Hormone Therapy and Radiation for High-risk Prostate CancerWho this might be right forProstate Cancer Memorial Sloan Kettering Cancer Center 50